newsfilter
← Latest News
GlobeNewswire·

Foghorn Therapeutics to Participate in Three Upcoming Investor Conferences in November

  • Foghorn Therapeutics Inc. (NASDAQ: FHTX) announced its management will attend the Guggenheim Third Annual Healthcare Innovation Conference, Stifel 2026 Healthcare Conference, & Jefferies 2026 London Healthcare Conference.
  • President & CEO Adrian Gottschalk will present at the Guggenheim fireside chat on Tuesday, November 10, 2026, at 3:30 p.m. ET, with webcast access available for 90 days.
  • Management will present at the Stifel 2026 Healthcare Conference on Wednesday, November 11, 2026, at 10:00 a.m. ET.
  • A fireside chat with management is scheduled for the Jefferies 2026 London Healthcare Conference on Monday, November 16, 2026, at 4:30 p.m. GMT.
  • One-on-one meetings with management will be available at all three conferences.
  • Foghorn Therapeutics develops novel medicines using oral small molecules, targeted protein degradation, & induced proximity for oncology & immunology & inflammation.